HIGHMARK COMMERCIAL MEDICAL POLICY - PENNSYLVANIA

 
 

Medical Policy:
I-8-095
Topic:
Immunizations
Section:
Injections
Effective Date:
July 29, 2024
Issued Date:
July 29, 2024
Last Revision Date:
July 2024
Annual Review:
September 2023
 
 

Refer to the current year’s Preventive Schedule for guidelines on the Provider Resource Center for when and how often the following immunizations are recommended. This schedule is a reference tool for planning preventive care, and lists items/services required under the Patient Protection and Affordable Care Act of 2010 (PPACA), as amended. It is reviewed and updated periodically based on the advice of the U.S. Preventive Services Task Force, laws and regulations and updates to clinical guidelines established by national medical organizations. Accordingly, the content of this schedule is subject to change. Specific needs for preventive immunizations may vary according to member’s personal risk factors.

Policy Position

Patient Protection and Affordable Care Act, as amended (PPACA) (Enacted 3/23/2010)
Comprehensive Guidelines supported by the Health Resources and Services Administration Bright Futures™American Academy of Pediatrics
Childhood Immunization Insurance Act (Act 35 of 1992)

Childhood Immunizations (Effective 11/21/1992)
Pennsylvania's Act 83 of 2002 (Effective 08/28/2002)

The following mandated immunizations are covered for the insured, the insured spouse, or a dependent child in accordance with the age limits of the individual contracts and CDC/ACIP recommendations.

  • Diphtheria
    • Diphtheria, tetanus toxoids, and acellular pertussis vaccine (DTaP),
    • Diphtheria and tetanus toxoids adsorbed (DT),
    • Diphtheria, tetanus toxoids, acellular pertussis vaccine and inactivated poliovirus vaccine (DTaP-IPV),
    • Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-Hep B),
    • Diphtheria, tetanus toxoids, acellular pertussis vaccine, Hepatitis B, and poliovirus vaccine, inactivated (DtaP-hyphenHep B-IPV)
  • Dengue (For children/adolescents ages 9 to 16 years old)
    • Dengue vaccine, quadrivalent, live, 2 dose or 3 dose schedule
  • Hemophilus B (HIB)
    • HIB vaccine, PRP-OMP conjugate, 3 dose schedule,
    • HIB vaccine, PRP-T conjugate, 4 dose schedule,
  • Hepatitis A (Hep A)
    • Hep A vaccine, adult dosage,
    • Hep A vaccine, pediatric/adolescent dosage-2 dose or 3 dose schedule,
    • Hepatitis A and Hepatitis B vaccine (Hep A- Hep B), adult dosage
    • Gamma globulin injection
  • Hepatitis B (Hep B)
    • Hep B vaccine, CPG-adjuvanted, adult dosage, 2 dose or 4 dose schedule,
    • Hep B vaccine, dialysis or immunosuppressed patient dosage, 3 dose or 4 dose schedule,
    • Hep B vaccine, adolescent, 2 dose or 3 dose schedule,
    • Hep B vaccine, pediatric/adolescent dosage, 3 dose schedule,
    • Hep B vaccine, adolescent/high risk infant dosage,
    • Hepatitis B and haemophilus influenzae type B vaccine (HIB-Hep B)
  • Influenza (vaccine recommended annually) (Note: not an all-inclusive list):  
    • Quadrivalent (IIV4), split virus, preservative free,
    • Inactivated (IIV), subunit, adjuvanted,
    • Trivalent (IIV3), split virus, preservative-free,
    • Influenza virus vaccine (IIV), split virus,
    • Quadrivalent, live (LAIV4), for intranasal use
    • Quadrivalent (CCIIV4), derived from cell cultures, subunit, preservative and antibiotic free
    • Trivalent (RIV3), derived from recombinant DNA (RIV3), hemagglutinin (HA) protein only, preservative and antibiotic free,
    • Quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free,
    • Influenza virus vaccine, split virus
  • Human Papillomavirus (HPV)
    • HPV vaccine, types 6, 11, 16, 18, quadrivalent (4VHPV), 3 dose schedule,
    • HPV vaccine, types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9VHPV), 2 or 3 dose schedule
  • Meningococcal
    • Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, tetanus toxoid carrier (MENACWY-TT),
    • Meningococcal recombinant protein and outer membrane vesicle vaccine, Serogroup B (MENB-4C), 2 dose schedule,
    • Meningococcal recombinant lipoprotein vaccine, Serogroup B (MENB-FHBP), 2 or 3 dose schedule,
    • Meningococcal conjugate vaccine, Serogroups C and Y and Haemophilus influenzae type B vaccine (HIB-MENCY), 4 dose schedule, when administered to children 6 weeks-18 months of age,
    • Meningococcal polysaccharide vaccine, Serogroups A, C, Y, W-135, quadrivalent (mpsv4),
    • Meningococcal conjugate vaccine, Serogroups A, C, W, Y, quadrivalent, diphtheria toxoid carrier (menacwy-d) or crm197 carrier (menacwy-crm)
  • Pneumonia
    • Pneumococcal conjugate, 13-valent (PCV13),
    • Pneumococcal polysaccharide, 23-valent,
    • Pneumococcal conjugate vaccine, 15-valent (PCV15),
    • Pneumococcal conjugate vaccine, 20-valent (PCV20)
  • Polio
    • Poliovirus vaccine, inactivated (IPV)
  • Rabies
    • Rabies immune globulin (RIG), human,
    • Rabies immune globulin, heat-treated (RIG-HT), human,
    • Rabies immune globulin, heat- and solvent/detergent-treated (RIG-HT S/D), human
  • Respiratory Syncytial Virus (RSV)
    • RSV Vaccine,
  • Rotavirus
    • Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use,
    • Rotavirus vaccine, human, attenuated (RV1), 2 dose schedule, live, for oral use
  • Rubeola (measles), Mumps, Rubella
    • Measles, Mumps and Rubella Virus Vaccine (MMR), live,
    • Measles, Mumps, Rubella, and Varicella Vaccine (MMRV), live,
    • Gamma globulin injection
  • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) (COVID-19) (Note: not an all-inclusive list):
    • DNA, spike protein, Adenovirus type 26 (AD 26) vector
    • MRNA-LNP, spike protein
  • Tetanus
    • Tetanus toxoid adsorbed,
    • Tetanus and diphtheria toxoids adsorbed (TD), preservative free, when administered to individuals 7 years or older,
    • Tetanus, diphtheria toxoids and acellular pertussis vaccine (TDaP), when administered to individuals 7 years or older
  • Varicella (chicken pox vaccine)
    • Varicella virus vaccine (VAR), live

0041A

0042A

0044A

90375

90376

90377

90380

90381

90460

90471

90480

90584

90587

90611

90619

90620

90621

90623

90630

90632

90633

90634

90636

90644

90647

90648

90649

90651

90653

90654

90655

90656

90657

90658

90660

90661

90662

90670

90671

90672

90673

90674

90677

90678

90679

90680

90681

90682

90683

90684

90685

90686

90687

90688

90694

90696

90697

90698

90700

90702

90703

90707

90710

90713

90714

90715

90716

90723

90732

90733

90734

90739

90740

90743

90744

90745

90746

90747

90748

90750

90756

91304

91318

91319

91320

91321

91322

96380

96381

J1560

M0201

Q2034

Q2035

Q2036

Q2037

Q2038

Q2039

 




Other Non-Mandated Immunizations

Other than those specific childhood immunizations listed above, coverage for immunizations is determined according to individual or group customer benefits. Immunizations should be reported under the appropriate procedure code. Immunization is acceptable for the following diseases:

  • Cholera
  • Diphtheria
  • Hemophilus B (HIB)
  • Hepatitis A 
  • Hepatitis B
  • Human Papillomavirus (HPV) 
  • Influenza 
  • Japanese encephalitis
  • Meningococcal (based on individual risk or physician recommendation: one or two doses per lifetime) 
  • Mumps
  • Pertussis (whooping cough)
  • Pneumonia
  • Plague
  • Polio
  • Rabies
  • Rubella
  • Rubeola (measles)
  • Shingles (herpes zoster)
  • Tetanus
  • Tuberculosis (BCG)
  • Typhoid fever
  • Varicella (chicken pox) 
  • Varicella-Zoster
  • Yellow fever

Immunizations or injections for diseases other than those listed above are not eligible for payment. Immunizations must be FDA approved to be eligible for payment. 

90585

90625

90630

90632

90647

90648

90653

90662

90670

90673

90674

90675

90676

90688

90690

90691

90694

90713

90716

90717

90732

90738

90739

90749

90750

 

 

 




NOTE: In addition to the above criteria, product specific dosage and/or frequency limits may apply in accordance with the U.S. Food and Drug Administration (FDA)-approved product prescribing information, national compendia, Centers for Medicare and Medicaid Services (CMS) and other peer reviewed resources or evidence-based guidelines. Highmark may deny, in full or in part, reimbursement for utilization that does not fall within the applicable dosage and/or frequency limits.


NOTE: A separate evaluation & management (E&M) code can be reported in addition to the administration of an immunization if a significant, separately identifiable E&M service is performed and documented in the individual's medical records. To justify these services, the individual's records must contain sufficient documentation regarding the appropriateness of performing both services, and documentation that the key components of the E&M service have been met. If the reported E&M service does not meet the component requirements, it will not be eligible for reimbursement. Payment for the immunization and the E&M service will also be subject to coverage limitations specified within the individual member's contract.


Related Policies

Refer to medical policy I-20 Immune Prophylaxis for Respiratory Syncytial Virus (RSV) for additional information.

Refer to medical policy I-14 Immune Globulin Therapy for additional information.

Refer to medical policy V-37 Autism Spectrum Disorders for additional information.



The policy position applies to all commercial lines of business



Links






This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical or other circumstances may warrant individual consideration, based on review of applicable medical records, as well as other regulatory, contractual and/or legal requirements.

Medical policies do not constitute medical advice, nor are they intended to govern the practice of medicine. They are intended to reflect Highmark's reimbursement and coverage guidelines. Coverage for services may vary for individual members, based on the terms of the benefit contract.

Highmark retains the right to review and update its medical policy guidelines at its sole discretion. These guidelines are the proprietary information of Highmark. Any sale, copying or dissemination of the medical policies is prohibited; however, limited copying of medical policies is permitted for individual use.

Discrimination is Against the Law
The Claims Administrator/Insurer complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. The Claims Administrator/Insurer does not exclude people or treat them differently because of race, color, national origin, age, disability, or sex. The Claims Administrator/ Insurer:

  • Provides free aids and services to people with disabilities to communicate effectively with us, such as:
    • Qualified sign language interpreters
    • Written information in other formats (large print, audio, accessible electronic formats, other formats)
  • Provides free language services to people whose primary language is not English, such as:
    • Qualified interpreters
    • Information written in other languages

If you need these services, contact the Civil Rights Coordinator.

If you believe that the Claims Administrator/Insurer has failed to provide these services or discriminated in another way on the basis of race, color, national origin, age, disability, or sex, you can file a grievance with: Civil Rights Coordinator, P.O. Box 22492, Pittsburgh, PA 15222, Phone: 1-866-286-8295, TTY: 711, Fax: 412-544-2475, email: CivilRightsCoordinator@highmarkhealth.org. You can file a grievance in person or by mail, fax, or email. If you need help filing a grievance, the Civil Rights Coordinator is available to help you.

You can also file a civil rights complaint with the U.S. Department of Health and Human Services, Office for Civil Rights electronically through the Office for Civil Rights Complaint Portal, available at https://ocrportal.hhs.gov/ocr/portal/lobby.jsf, or by mail or phone at:

U.S. Department of Health and Human Services
200 Independence Avenue, SW
Room 509F, HHH Building
Washington, D.C. 20201
1-800-368-1019, 800-537-7697 (TDD)

Complaint forms are available at http://www.hhs.gov/ocr/office/file/index.html.

This information is issued by Highmark Blue Shield on behalf of its affiliated Blue companies, which are independent licensees of the Blue Cross Blue Shield Association.  Highmark Inc. d/b/a Highmark Blue Shield and certain of its affiliated Blue companies serve Blue Shield members in the 21 counties of central Pennsylvania. As a partner in joint operating agreements, Highmark Blue Shield also provides services in conjunction with a separate health plan in southeastern Pennsylvania.  Highmark Inc. or certain of its affiliated Blue companies also serve Blue Cross Blue Shield members in 29 counties in western Pennsylvania, 13 counties in northeastern Pennsylvania, the state of West Virginia plus Washington County, Ohio, the state of Delaware[ and [8] counties in western New York and Blue Shield members in [13] counties in northeastern New York].  All references to Highmark in this document are references to Highmark Inc. d/b/a Highmark Blue Shield and/or to one or more of its affiliated Blue companies.





Medical policies do not constitute medical advice, nor are they intended to govern the practice of medicine. They are intended to reflect reimbursement and coverage guidelines. Coverage for services may vary for individual members, based on the terms of the benefit contract.

Discrimination is Against the Law
The Claims Administrator/Insurer complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. The Claims Administrator/Insurer does not exclude people or treat them differently because of race, color, national origin, age, disability, or sex. The Claims Administrator/ Insurer:

  • Provides free aids and services to people with disabilities to communicate effectively with us, such as:
  • Qualified sign language interpreters
  • Written information in other formats (large print, audio, accessible electronic formats, other formats)

  • Provides free language services to people whose primary language is not English, such as:
  • Qualified interpreters
  • Information written in other languages
  • If you need these services, contact the Civil Rights Coordinator.

    If you believe that the Claims Administrator/Insurer has failed to provide these services or discriminated in another way on the basis of race, color, national origin, age, disability, or sex, you can file a grievance with: Civil Rights Coordinator, P.O. Box 22492, Pittsburgh, PA 15222, Phone: 1-866-286-8295 , TTY: 711, Fax: 412-544-2475, email: CivilRightsCoordinator@highmarkhealth.org. You can file a grievance in person or by mail, fax, or email. If you need help filing a grievance, the Civil Rights Coordinator is available to help you.

    You can also file a civil rights complaint with the U.S. Department of Health and Human Services, Office for Civil Rights electronically through the Office for Civil Rights Complaint Portal, available at https://ocrportal.hhs.gov/ocr/portal/lobby.jsf, or by mail or phone at:

    U.S. Department of Health and Human Services
    200 Independence Avenue, SW
    Room 509F, HHH Building
    Washington, D.C. 20201
    1-800-368-1019, 800-537-7697 (TDD)

    Complaint forms are available at http://www.hhs.gov/ocr/office/file/index.html.